Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


RDM researchers are leading one of the six new NIHR-BHF COVID-19 projects.

The project takes advantage of novel artificial intelligence (AI) techniques applied to CT chest scans to accurately measure the level of inflammation in the heart which is suspected to be a cause of severe responses to the virus. CT scans are now frequently used to estimate the involvement of the lungs and hearts of COVID-19 patients.

These AI methods were developed by Professor Charalambos Antoniades, who will lead the project with collaborators across the UK.

Linking their results to the data generated in the other Flagship Projects will guide the use of anti-inflammatory drugs in COVID-19 patients. This study will be strengthened by the availability of previous CT scans in many patients with existing heart disease and repeat CT scans after infection has subsided. This will allow a direct comparison of inflammation before, during and after infection to understand whether COVID-19 has lasting effects on heart health and therefore whether these patients should be treated more actively with medicines to reduce their cardiovascular risk.

Similar stories

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.